GOLDMAN SACHS GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for INDIVIOR PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share (INDV)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: INDIVIOR PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share
Symbol: INDV
Shares outstanding: 123,876,924 shares
Disclosed Ownership: 3,592,431 shares
Ownership: 2.9%
Form type: SCHEDULE 13G/A
Filing time: 12 Feb 2026, 10:30:40 UTC
Date of event: 31 Dec 2025
Previous filing: 12 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	2.9%	3,592,431	0	3,592,396	Name: Veronica Mupazviriwo	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	2.9%	3,592,431	0	3,592,396	Name: Veronica Mupazviriwo	Attorney-in-fact